Vaginal Slings Market Repository of Analysis and Information for Every Facet of the Market, Key players in the Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific,
Vaginal Slings Market Repository of Analysis and Information for Every Facet of the Market, Key players in the Seracare Life Sciences, Inc., Zeptometrix, Thermo Fisher Scientific,
Published by Coherent Market Insights
Posted on September 20, 2021
Global Vaginal Slings Market
Vaginal slings are used to manage urinary incontinence, an undiagnosed condition in which an involuntary leakage of urine occurs due to losing control over the bladder. Laughing, coughing, sneezing, lifting of heavy things, and exercising are some of the activities that usually lead to urine leakage in people affected by this condition. Vaginal slings serve as a hammock that upholds and supports the urethra and bladder to prevent urine leakage.
There are several types of slings available in the market, such as sub-urethral and pubovaginal slings. The placing of pubovaginal slings involve minimally invasive surgical procedures (a vaginal incision sling is placed). Whereas, the sub-urethral slings are placed around the urethra and are attached to the abdominal wall. Thus, the sling surgery is a common form of surgery, in which the slings are made of materials, such as human tissue, cadaver tissue, pig or cow tissue, and mesh (synthetic materials).
Global Vaginal Slings Market Dynamics
Rising prevalence of urinary incontinence is expected to drive the global vaginal slings market growth over the forecast period. According to the Global Forum of Incontinence (GFI), in 2018 incidence of urinary incontinence is higher in females compared to males. The same source reported that the prevalence rate of urinary incontinence in women, aged 20 years and above, is found to be around 12.4%, and 45% in women above the age of 40 years. Moreover, majority of these women are claimed to be suffering from daily urinary incontinence and stress urinary incontinence. The source further reported that 51% of females usually suffer from stress urinary incontinence, around 11% suffer from urge urinary incontinence, while 17% are affected by mixed urinary incontinence. As a consequence, the high global incidence rate of urinary continence is expected to boost the demand for vaginal slings in the near future.
Vaginal slings placed using minimally invasive procedures are expected to witness significant growth in global vaginal slings market as compared to slings placed using invasive procedures. Key players in the market are focused on launching products for treatment of urinary incontinence. For instance, in 2013, American Medical Systems (AMS) launched the MiniArc Pro single-incision sling system for treating stress urinary incontinence in women. Moreover, Boston Scientific has innovative product line for treatment of urinary incontinence such as Advantage System, Obtryx System, and Lynx System. Moreover, reimbursements for vaginal sling placement procedures are available from organizations such as Centers for Medicare & Medicaid Services (CMS). Such factors are expected to propel global vaginal slings market growth over the estimated period.
Global Vaginal Slings Market – Regional Analysis
North America is expected to dominate the global vaginal slings market in the foreseeable future, due to the high prevalence of urinary incontinence in the region. According to the Global Forum of Incontinence (GFI), in 2018, the prevalence rate of urinary incontinence in the U.S. was found to be 9%.
The same source, further reported that Europe is expected to support global vaginal slings market growth due to high prevalence of urinary incontinence (9.9%). Moreover, in Africa, the prevalence rate of urinary incontinence was valued to be 7.2%, which is expected to drive the global vaginal slings market growth. The government of Australia initiated a Continence Aids Payment Scheme (CAPS) in 2010, which assists individuals with permanent and severe incontinence by providing financial assistance to support the treatment cost for their continence products.
Current and future of global Vaginal Slings Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Global Vaginal Slings Market Restraints
One of the major factors restraining the growth of the global vaginal slings market is the availability of alternate treatments for urinary incontinence, other than vaginal slings. Alternative treatments include drugs such as anticholinergic, mirabegron, alpha blockers, topical estrogen, and other products, such as Transvaginal mesh used by doctors to repair weakened or damaged tissue in the bladder. In 2017, the National Center for Biotechnology Information (NCBI) had reported adverse effects of single-incision sling mesh, such as vaginal mesh perforations, mesh erosion, and urinary retention. Such factors are likely to result in complete sling removal or partial sling removal as per severity of their side effects. The NCBI also reported complications resulting from sub-urethral slings, such as bleeding, injury to the urethra or bladder, urethral or bladder mesh erosion, vaginal extrusion of mesh, intestinal perforation, and urinary tract infection (UTI).
Global Vaginal Slings Market – Leading Players
Some of the major players operating in the global vaginal slings market are Boston Scientific Corporation, Coloplast, C.R. Bard, Ethicon, Inc., Betatech Medical, Caldera Medical, Medtronic Plc, Analytic Biosurgical solution (ABISS), Agency for Medical Innovations (A.M.I. GmbH), and Promedon Group.
Vaginal slings are used to manage urinary incontinence, an undiagnosed condition in which an involuntary leakage of urine occurs due to losing control over the bladder. Laughing, coughing, sneezing, lifting of heavy things, and exercising are some of the activities that usually lead to urine leakage in people affected by this condition. Vaginal slings serve as a hammock that upholds and supports the urethra and bladder to prevent urine leakage.
There are several types of slings available in the market, such as sub-urethral and pubovaginal slings. The placing of pubovaginal slings involve minimally invasive surgical procedures (a vaginal incision sling is placed). Whereas, the sub-urethral slings are placed around the urethra and are attached to the abdominal wall. Thus, the sling surgery is a common form of surgery, in which the slings are made of materials, such as human tissue, cadaver tissue, pig or cow tissue, and mesh (synthetic materials).
Global Vaginal Slings Market Dynamics
Rising prevalence of urinary incontinence is expected to drive the global vaginal slings market growth over the forecast period. According to the Global Forum of Incontinence (GFI), in 2018 incidence of urinary incontinence is higher in females compared to males. The same source reported that the prevalence rate of urinary incontinence in women, aged 20 years and above, is found to be around 12.4%, and 45% in women above the age of 40 years. Moreover, majority of these women are claimed to be suffering from daily urinary incontinence and stress urinary incontinence. The source further reported that 51% of females usually suffer from stress urinary incontinence, around 11% suffer from urge urinary incontinence, while 17% are affected by mixed urinary incontinence. As a consequence, the high global incidence rate of urinary continence is expected to boost the demand for vaginal slings in the near future.
Vaginal slings placed using minimally invasive procedures are expected to witness significant growth in global vaginal slings market as compared to slings placed using invasive procedures. Key players in the market are focused on launching products for treatment of urinary incontinence. For instance, in 2013, American Medical Systems (AMS) launched the MiniArc Pro single-incision sling system for treating stress urinary incontinence in women. Moreover, Boston Scientific has innovative product line for treatment of urinary incontinence such as Advantage System, Obtryx System, and Lynx System. Moreover, reimbursements for vaginal sling placement procedures are available from organizations such as Centers for Medicare & Medicaid Services (CMS). Such factors are expected to propel global vaginal slings market growth over the estimated period.
Global Vaginal Slings Market – Regional Analysis
North America is expected to dominate the global vaginal slings market in the foreseeable future, due to the high prevalence of urinary incontinence in the region. According to the Global Forum of Incontinence (GFI), in 2018, the prevalence rate of urinary incontinence in the U.S. was found to be 9%.
The same source, further reported that Europe is expected to support global vaginal slings market growth due to high prevalence of urinary incontinence (9.9%). Moreover, in Africa, the prevalence rate of urinary incontinence was valued to be 7.2%, which is expected to drive the global vaginal slings market growth. The government of Australia initiated a Continence Aids Payment Scheme (CAPS) in 2010, which assists individuals with permanent and severe incontinence by providing financial assistance to support the treatment cost for their continence products.
Current and future of global Vaginal Slings Market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period.
The latest developments, market shares, and strategies that are employed by the major market players.
Global Vaginal Slings Market Restraints
One of the major factors restraining the growth of the global vaginal slings market is the availability of alternate treatments for urinary incontinence, other than vaginal slings. Alternative treatments include drugs such as anticholinergic, mirabegron, alpha blockers, topical estrogen, and other products, such as Transvaginal mesh used by doctors to repair weakened or damaged tissue in the bladder. In 2017, the National Center for Biotechnology Information (NCBI) had reported adverse effects of single-incision sling mesh, such as vaginal mesh perforations, mesh erosion, and urinary retention. Such factors are likely to result in complete sling removal or partial sling removal as per severity of their side effects. The NCBI also reported complications resulting from sub-urethral slings, such as bleeding, injury to the urethra or bladder, urethral or bladder mesh erosion, vaginal extrusion of mesh, intestinal perforation, and urinary tract infection (UTI).
Global Vaginal Slings Market – Leading Players
Some of the major players operating in the global vaginal slings market are Boston Scientific Corporation, Coloplast, C.R. Bard, Ethicon, Inc., Betatech Medical, Caldera Medical, Medtronic Plc, Analytic Biosurgical solution (ABISS), Agency for Medical Innovations (A.M.I. GmbH), and Promedon Group.